• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.

作者信息

Hinderling P H, Garrett E R

出版信息

J Pharmacokinet Biopharm. 1976 Jun;4(3):199-230. doi: 10.1007/BF01063614.

DOI:10.1007/BF01063614
PMID:978389
Abstract
摘要

相似文献

1
Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.抗心律失常药双异丙吡胺在健康人体内的药代动力学。
J Pharmacokinet Biopharm. 1976 Jun;4(3):199-230. doi: 10.1007/BF01063614.
2
Disopyramide pharmacokinetics and bioavailability.丙吡胺的药代动力学和生物利用度。
Br J Clin Pharmacol. 1978 Sep;6(3):279-81. doi: 10.1111/j.1365-2125.1978.tb04598.x.
3
The pharmacokinetics of Norpace.心律平的药代动力学。
Angiology. 1975 Jan;26(1 Pt 2):85-98.
4
[Pharmacokinetic and metabolic study of disopyramide in oral and intravenous administration].
Therapie. 1977 Mar-Apr;32(2):195-204.
5
Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.丙吡胺血清及药理效应动力学在生物利用度评估中的应用。
Br J Clin Pharmacol. 1978 Nov;6(5):409-19. doi: 10.1111/j.1365-2125.1978.tb04605.x.
6
Influence of renal failure on disopyramide pharmacokinetics [proceedings].
Br J Clin Pharmacol. 1979 Apr;7(4):427P-428P. doi: 10.1111/j.1365-2125.1979.tb00972.x.
7
Clinical pharmacokinetics of disopyramide.丙吡胺的临床药代动力学。
J Pharmacokinet Biopharm. 1982 Oct;10(5):465-94. doi: 10.1007/BF01059032.
8
Pharmacokinetics of disopyramide administered by intramuscular, intravenous and oral routes to normal volunteers [proceedings].双异丙吡胺经肌肉注射、静脉注射和口服途径给予正常志愿者后的药代动力学[会议记录]
Br J Pharmacol. 1979 Jul;66(3):442P-443P.
9
Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia.丙吡胺的药代动力学与室性快速心律失常疗效的相关性。
J Int Med Res. 1976;4(1 Suppl):54-8.
10
Placental and milk transfer of disopyramide and metabolites.
Drug Metab Dispos. 1978 May-Jun;6(3):346-8.

引用本文的文献

1
Therapeutic drug monitoring: antiarrhythmic drugs.治疗药物监测：抗心律失常药物
Br J Clin Pharmacol. 1998 Oct;46(4):307-19. doi: 10.1046/j.1365-2125.1998.t01-1-00768.x.
2
A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes.美罗培南在静脉注射2分钟、3分钟和5分钟后的药代动力学比较。
Eur J Drug Metab Pharmacokinet. 1997 Jul-Sep;22(3):193-9. doi: 10.1007/BF03189806.
3
Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment.肾功能损害患者口服磷酸丙吡胺的药代动力学。

本文引用的文献

1
CLINICAL STUDIES OF THE BLOOD VOLUME. I. CLINICAL APPLICATION OF A METHOD EMPLOYING THE AZO DYE "EVANS BLUE" AND THE SPECTROPHOTOMETER.血容量的临床研究。I. 一种使用偶氮染料“伊文思蓝”和分光光度计的方法的临床应用。
J Clin Invest. 1937 May;16(3):301-16. doi: 10.1172/JCI100859.
2
A COMPARISON OF THE ANTIFIBRILLATORY ACTIONS AND EFFECTS ON INTRACELLULAR CARDIAC POTENTIALS OF PRONETHALOL, DISOPYRAMIDE AND QUINIDINE.心得安、双异丙吡胺和奎尼丁的抗纤颤作用及对细胞内心脏电位影响的比较
Br J Pharmacol Chemother. 1963 Dec;21(3):473-81. doi: 10.1111/j.1476-5381.1963.tb02015.x.
3
Clinical evaluation of a new anti-arrhythmic agent, SC-7031.
Br J Clin Pharmacol. 1980 Sep;10(3):245-8. doi: 10.1111/j.1365-2125.1980.tb01751.x.
4
Plasma binding of disopyramide.丙吡胺的血浆结合
Br J Clin Pharmacol. 1980 Jun;9(6):614-8. doi: 10.1111/j.1365-2125.1980.tb01090.x.
5
Comparative bioavailability of disopyramide after multiple dosing with standard capsules and controlled-release tablets.丙吡胺标准胶囊与控释片多次给药后的生物利用度比较
Eur J Clin Pharmacol. 1980;17(3):209-13. doi: 10.1007/BF00561902.
6
Enhanced metabolism and diminished efficacy of disopyramide by enzyme induction?酶诱导作用会增强丙吡胺的代谢并降低其疗效吗？
Br J Clin Pharmacol. 1980 Feb;9(2):149-52. doi: 10.1111/j.1365-2125.1980.tb05825.x.
7
Quantitative analysis of the disopyramide concentration-effect relationship.丙吡胺浓度-效应关系的定量分析。
Br J Clin Pharmacol. 1980 Jan;9(1):67-75. doi: 10.1111/j.1365-2125.1980.tb04799.x.
8
Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure.丙吡胺在近期发生至中度心力衰竭患者中的药代动力学。
Eur J Clin Pharmacol. 1981 Feb;19(3):187-92. doi: 10.1007/BF00561947.
9
The effect of enzyme induction on the metabolism of disopyramide in man.酶诱导对人丙吡胺代谢的影响。
Br J Clin Pharmacol. 1981 Mar;11(3):279-85. doi: 10.1111/j.1365-2125.1981.tb00535.x.
10
Pharmacokinetics and pharmacodynamics of the antiarrhythmic compound MD750819 in dogs with experimentally induced arrhythmias.
J Pharmacokinet Biopharm. 1982 Jun;10(3):283-96. doi: 10.1007/BF01059262.
新型抗心律失常药物SC-7031的临床评估
Curr Ther Res Clin Exp. 1963 Jul;5:343-50.
4
Endogenous creatinine clearance. A valuable clinical test of glomerular filtration and a prognostic guide in chronic renal disease.内生肌酐清除率。一项评估肾小球滤过功能的重要临床检测指标，也是慢性肾病的预后指导指标。
N Engl J Med. 1962 Feb 15;266:317-23. doi: 10.1056/NEJM196202152660701.
5
[A new antiarrhythmic agent: disopyramide].
Presse Med (1893). 1968 Sep 7;76(32):1605-6.
6
Influence of first-pass effect on availability of drugs on oral administration.首过效应对口服给药时药物可利用度的影响。
J Pharm Sci. 1971 Sep;60(9):1338-40. doi: 10.1002/jps.2600600909.
7
Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve.给药途径对血浆浓度-时间曲线下面积影响的药代动力学基础。
J Pharm Sci. 1969 Dec;58(12):1477-80. doi: 10.1002/jps.2600581211.
8
Effects of protein bindings of drugs on areas under plasma concentration--time curves.药物蛋白结合对血浆浓度-时间曲线下面积的影响。
J Pharm Sci. 1972 Jan;61(1):138-9. doi: 10.1002/jps.2600610134.
9
Effect of parallel first-order loss from site of administration on calculated values for absorption rate constants.
J Pharm Sci. 1972 Jan;61(1):135-8. doi: 10.1002/jps.2600610133.
10
Integral coefficients of multi-compartment pharmacokinetic models. Application to chemotherapy.
Chemotherapy. 1972;17(2):109-20. doi: 10.1159/000220844.